Novartis says experimental multiple sclerosis treatment FTY720 is linked to death and infection

Novartis SA, Switzerland's second- largest drugmaker, said a patient died and another developed a serious infection in tests of its experimental multiple sclerosis treatment FTY720.
Read article at bloomberg.com